Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2008, for Spatializer Audio Laboratories, Inc. (Note: The input metadata referenced "Enveric Biosciences," but the filing text explicitly identifies the registrant as Spatializer Audio Laboratories, Inc.). The company, formerly a developer of audio signal processing technologies, ceased commercial operations in 2006. On July 2, 2007, it sold substantially all of its operating assets to a subsidiary of DTS, Inc. The company is currently in a wind-down phase with no active revenue-generating business model.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Revenues | $0 | $359,684 |
| Net Income (Loss) | $(64,391) | $233,657 |
| Operating Expenses | $70,682 | $97,157 |
| Cash and Cash Equivalents (End of Period) | $1,527,128 | $726,276 |
| Working Capital | $1,492,714 | N/A |
| Total Debt | $0 | $9,680 |
| Accumulated Deficit | $(45,792,141) | N/A |
Liquidity: The company held $1,527,128 in cash and cash equivalents and $1,000,000 in short-term investments as of March 31, 2008. Current liabilities totaled $42,256.
Material Changes vs. Prior Period
- Revenue Collapse: Revenues dropped 100% to $0 compared to $359,684 in Q1 2007. This is a direct result of the July 2007 sale of all operating assets to DTS, Inc., eliminating the company's royalty income stream.
- Profitability Shift: The company swung from a net income of $233,657 in Q1 2007 to a net loss of $64,391 in Q1 2008. The loss is attributed to general and administrative expenses required to maintain the corporate shell in the absence of operations.
- Expense Reduction: Operating expenses decreased by approximately 27% ($26,475) year-over-year, driven by the elimination of sales, marketing, and R&D costs following the cessation of operations.
- Debt Elimination: A note payable of $9,680 outstanding at the end of 2007 was paid in full during Q1 2008.
Outlook, Risks, and Subsequent Events
Going Concern: Management explicitly states that the company's circumstances raise substantial doubt about its ability to continue as a going concern. There is no current source of future cash flow, and the company cannot maintain its liquidity position without a new business model and outside funding.
Subsequent Events (Post-March 31, 2008):
- Cash Dividend: On April 22, 2008, the company distributed a special cash dividend of $1,365,000 ($0.021 per share) to stockholders, leaving a residual cash balance of approximately $109,915.
- Change in Control: Effective April 28, 2008, the previous board members resigned, and a new investor group (led by Jay A. Gottlieb) took control of management. The new management may pursue a new business plan, though no assurance of success is provided.
- Internal Controls: The filing discloses a material weakness in internal controls due to limited segregation of duties, as the company operated with only one part-time employee and a contract bookkeeper.
Investor Verification Checklist
- Verify the status of the $109,915 residual cash balance remaining after the April 2008 dividend distribution.
- Confirm the specific new business plan or strategy proposed by the new management team appointed in April 2008.
- Review the change of control implications on the company's $26 million in Net Operating Loss (NOL) carryforwards, which are likely restricted or unusable.
- Assess the material weakness in internal controls and the adequacy of financial reporting oversight with the current minimal staff.
- Check for any legal claims arising from the July 2007 asset sale to DTS, Inc., which had a nine-month indemnification period.